Veeva Systems

Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency

Retrieved on: 
Thursday, January 11, 2024
Veeva Systems, Central nervous system, CNS, Cryptocurrency

BARCELONA, Spain, Jan. 11, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process. By adopting a validation solution with built-in best practices, the company can execute digital validation while centralizing data and improving visibility.

Key Points: 
  • By adopting a validation solution with built-in best practices, the company can execute digital validation while centralizing data and improving visibility.
  • "As the industry continues to shift from traditional paper-based validation, more companies are advancing validation with Veeva Vault Validation Management to streamline and standardize processes," said Nina Ricciardelli, director, Veeva Vault Validation Management.
  • The company is building off its success with Veeva Vault QualityDocs and Veeva Vault QMS to optimize its validation programs, driving greater compliance and traceability across all systems.
  • "Veeva Vault Validation Management allows us to further simplify our validation process for significant cost and time-savings in test execution," said Hina Patel, vice president and global head of quality assurance, SK Life Science, Inc. "Using an advanced validation solution helps improve our efficiency, data integrity, and audit readiness."

Veeva to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 8, 2024
Veeva Systems, Conference

PLEASANTON, Calif., Jan. 8, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Peter Gassner, founder and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 2:15 p.m. PT in San Francisco.

Key Points: 
  • PLEASANTON, Calif., Jan. 8, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Peter Gassner, founder and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 2:15 p.m. PT in San Francisco.
  • The presentation will be webcast.
  • Links to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com .

Assignment-Free Training - Cultivating a Training-Positive Mindset, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, January 8, 2024
Veeva Systems, L&D, JD, Learning, Senior

TORONTO, ON, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Discover this informative webinar delving into improved training outcomes by moving from a traditional compliance program to a learner-driven training culture. Better approaches are needed when managing the typical challenges of getting users to complete training on time, facing compliance risk and trying to scale with businesses.

Key Points: 
  • In this free webinar, delve into improved training outcomes by moving from a traditional compliance program to a learner-driven training culture.
  • The speakers will share training strategies to ensure readiness for inspection and lessons learned during the training transformation process.
  • TORONTO, ON, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Discover this informative webinar delving into improved training outcomes by moving from a traditional compliance program to a learner-driven training culture.
  • They will share how to:
    Join this webinar to receive actionable recommendations and strategies to help improve training programs and outcomes.

Veeva Announces Fiscal 2024 Third Quarter Results

Retrieved on: 
Wednesday, December 6, 2023
Cloud, Momentum, NYSE, CFO, CRM, Data wrangling, Interactive Fiction Technology Foundation, TFC, Marketing, Align Biopharma, Automation, Q&A, Software, Drug development, Growth, Telecommunications, Pharmaceutical industry, Video game, Livestock, Life insurance, Cryptocurrency, Compass, Veeva Systems

PLEASANTON, Calif., Dec. 6, 2023 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2023.

Key Points: 
  • Fiscal 2024 Third Quarter Results:
    Revenues: Total revenues for the third quarter were $616.5 million, up from $552.4 million one year ago, an increase of 12% year over year.
  • Veeva is providing guidance for its fiscal fourth quarter ending January 31, 2024 as follows:
    Total revenues between $620 and $622 million.
  • Veeva is providing updated guidance for its fiscal year ending January 31, 2024 as follows:
    Total revenues between $2,353 and $2,355 million.
  • Veeva is reiterating guidance for its fiscal year ending January 31, 2025 for the following metrics:
    Total revenues of at least $2,750 million.

Canopy Launches Content Innovation Solutions with hiring of key Life Sciences Executives

Retrieved on: 
Tuesday, December 5, 2023
IQVIA, Patient, Software, DAM, Growth, Fine chemical, Canopy, Veeva Systems

DANBURY, Conn., Dec. 5, 2023 /PRNewswire/ -- Canopy Life Sciences ("Canopy"), a provider of clinical to commercial solutions to the life sciences industry, announced today the launch of Content Innovation Solutions, a new division of the company which will deliver services and technology that focus on eliminating inefficiencies inherent within the Life Sciences content supply chain.

Key Points: 
  • DANBURY, Conn., Dec. 5, 2023 /PRNewswire/ -- Canopy Life Sciences ("Canopy"), a provider of clinical to commercial solutions to the life sciences industry, announced today the launch of Content Innovation Solutions, a new division of the company which will deliver services and technology that focus on eliminating inefficiencies inherent within the Life Sciences content supply chain.
  • "With over 175 content specialists, Canopy is already recognized as the industry leader in the review and approval of medical and promotional content.
  • Our goal is to build content solutions that enable our Life Sciences customers to engage with HCPs and patients more quickly and clearly resulting in improved patient outcomes."
  • We believe by addressing the inefficiencies inherent within the current Life Sciences content lifecycle we will accelerate the speed at which content can be delivered to the marketplace."

Bayer Commits to Veeva Vault CRM and Veeva OpenData Globally

Retrieved on: 
Monday, November 27, 2023
Cloud, HCP, NYSE, CRM, Align Biopharma, Veeva Systems, Partnership, Pharmaceutical industry, Bayer

PLEASANTON, Calif., Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, while also standardizing global customer data with Veeva OpenData. As Bayer moves to Vault CRM, the next generation of CRM for life sciences, it is harmonizing customer reference data for greater efficiency and continued innovation into the future. By unifying its global master data, Bayer will be poised to leverage AI-driven engagement across channels and geographies.

Key Points: 
  • PLEASANTON, Calif., Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, while also standardizing global customer data with Veeva OpenData .
  • "Vault CRM and Veeva OpenData are essential to driving more precise and effective customer engagement in every region and therapeutic area."
  • "Vault CRM and Veeva OpenData will provide the foundation for commercial innovation to drive more effective on-demand engagement, expanding HCP relationships worldwide."
  • Veeva OpenData is part of Veeva Data Cloud , the modern data platform for life sciences that connects commercial and clinical for greater precision and speed.

Top Biopharma Commits to Veeva Vault CRM for Global Customer Engagement

Retrieved on: 
Monday, November 27, 2023
Cloud, HCP, NYSE, CRM, Patient, Marketing, GSK, Digital technology, Partnership, Pharmaceutical industry, Veeva Systems

PLEASANTON, Calif., Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM. By adopting the next generation of CRM for life sciences, GSK plans to unlock the new technology innovation to interact with customers based on their needs and in ways that work best for them, leading to more effective healthcare professional (HCP) engagement.

Key Points: 
  • PLEASANTON, Calif., Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM .
  • Vault CRM will include the full functionality of market-leading Veeva CRM on the Veeva Vault Platform , unlocking new opportunities for more connected, customer-centric engagement across sales, medical, and marketing.
  • Vault CRM is part of Veeva Commercial Cloud , the technology foundation for commercial innovation.
  • "GSK will continue its forward-thinking approach to customer relationships by taking full advantage of Vault CRM and future innovations."

Bayer Commits to Veeva Vault CRM and Veeva OpenData Globally

Retrieved on: 
Monday, November 27, 2023
Cloud, HCP, NYSE, CRM, Align Biopharma, Veeva Systems, Partnership, Pharmaceutical industry, Bayer

BARCELONA, Spain, Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, while also standardizing global customer data with Veeva OpenData. As Bayer moves to Vault CRM, the next generation of CRM for life sciences, it is harmonizing customer reference data for greater efficiency and continued innovation into the future. By unifying its global master data, Bayer will be poised to leverage AI-driven engagement across channels and geographies.

Key Points: 
  • BARCELONA, Spain, Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, while also standardizing global customer data with Veeva OpenData .
  • "Vault CRM and Veeva OpenData are essential to driving more precise and effective customer engagement in every region and therapeutic area."
  • "Vault CRM and Veeva OpenData will provide the foundation for commercial innovation to drive more effective on-demand engagement, expanding HCP relationships worldwide."
  • Veeva OpenData is part of Veeva Data Cloud , the modern data platform for life sciences that connects commercial and clinical for greater precision and speed.

Top Biopharma Commits to Veeva Vault CRM for Global Customer Engagement

Retrieved on: 
Monday, November 27, 2023
Cloud, HCP, NYSE, CRM, Patient, Marketing, GSK, Digital technology, Partnership, Pharmaceutical industry, Veeva Systems

BARCELONA, Spain, Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM. By adopting the next generation of CRM for life sciences, GSK plans to unlock the new technology innovation to interact with customers based on their needs and in ways that work best for them, leading to more effective healthcare professional (HCP) engagement.

Key Points: 
  • BARCELONA, Spain, Nov. 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM .
  • Vault CRM will include the full functionality of market-leading Veeva CRM on the Veeva Vault Platform , unlocking new opportunities for more connected, customer-centric engagement across sales, medical, and marketing.
  • Vault CRM is part of Veeva Commercial Cloud , the technology foundation for commercial innovation.
  • "GSK will continue its forward-thinking approach to customer relationships by taking full advantage of Vault CRM and future innovations."

Veeva to Release Fiscal 2024 Third Quarter Results on December 6, 2023

Retrieved on: 
Wednesday, November 15, 2023
Veeva Systems, NYSE, Communications satellite

PLEASANTON, Calif., Nov. 15, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2023, after market close on December 6, 2023.

Key Points: 
  • PLEASANTON, Calif., Nov. 15, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2023, after market close on December 6, 2023.
  • Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m.
  • Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m.
  • ET).